NO20075671L - Neurodegenerative markorer for psykiatriske tilstander - Google Patents

Neurodegenerative markorer for psykiatriske tilstander

Info

Publication number
NO20075671L
NO20075671L NO20075671A NO20075671A NO20075671L NO 20075671 L NO20075671 L NO 20075671L NO 20075671 A NO20075671 A NO 20075671A NO 20075671 A NO20075671 A NO 20075671A NO 20075671 L NO20075671 L NO 20075671L
Authority
NO
Norway
Prior art keywords
psychiatric conditions
markers
neurodegenerative
disease
values
Prior art date
Application number
NO20075671A
Other languages
English (en)
Inventor
Aye Mu Myint
Manfred Schawaller
Robert Verkerk
Markus J Schwarz
Harald Hampel
Norbert Mueller
Original Assignee
Klinik Und Poliklinik Fuer Psy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinik Und Poliklinik Fuer Psy filed Critical Klinik Und Poliklinik Fuer Psy
Publication of NO20075671L publication Critical patent/NO20075671L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)

Abstract

Oppfinnelsen angår fremgangsmåter for å påvise en psykiatrisk tilstand eventuelt forbundet med en deteksjon omfattende trinnene av å måle konsentrasjonen av minst et in vivo degraderingsprodukt av tryptofan. Videre angår oppfinnelsen anvendelse av nevnte verdier som prediktive markører for deteksjon av en psykiatrisk tilstand eventuelt forbundet med en depresjon og et kitt inneholdende midler for å påvise disse verdier.
NO20075671A 2005-04-06 2007-11-06 Neurodegenerative markorer for psykiatriske tilstander NO20075671L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
PCT/EP2006/002907 WO2006105907A1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for psychiatric conditions

Publications (1)

Publication Number Publication Date
NO20075671L true NO20075671L (no) 2007-11-06

Family

ID=36293430

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20075671A NO20075671L (no) 2005-04-06 2007-11-06 Neurodegenerative markorer for psykiatriske tilstander
NO20120452A NO20120452L (no) 2005-04-06 2012-04-18 Neurodegenerative markorer for psykiatriske tilstander

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20120452A NO20120452L (no) 2005-04-06 2012-04-18 Neurodegenerative markorer for psykiatriske tilstander

Country Status (14)

Country Link
US (2) US20080131921A1 (no)
EP (2) EP2146209B1 (no)
JP (1) JP4958893B2 (no)
AT (2) ATE468537T1 (no)
CY (1) CY1110116T1 (no)
DE (1) DE602006014379D1 (no)
DK (2) DK2146209T3 (no)
ES (2) ES2346467T3 (no)
HK (1) HK1137219A1 (no)
NO (2) NO20075671L (no)
PL (2) PL2146209T3 (no)
PT (2) PT2146209E (no)
SI (1) SI1866650T1 (no)
WO (1) WO2006105907A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5856364B2 (ja) * 2006-08-04 2016-02-09 味の素株式会社 抑うつ病の評価方法、抑うつ病評価装置、抑うつ病評価方法、抑うつ病評価システム、抑うつ病評価プログラム、記録媒体および端末装置
AT9843U1 (de) * 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
BR122018069446B8 (pt) 2008-01-18 2021-07-27 Harvard College método in vitro para detectar a presença de um célula de câncer em um indivíduo
WO2009096502A1 (ja) * 2008-01-31 2009-08-06 Japan As Represented By President Of National Center Of Neurology And Psychiatry うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
CN104777314B (zh) 2009-08-12 2017-01-04 福满代谢组技术有限公司 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质
WO2012012717A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
KR20130041962A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 식작용 세포를 사용하여 질환 또는 상태를 검출하는 방법
KR20130041961A (ko) 2010-07-23 2013-04-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 체액에서 질환 또는 상태의 특징을 검출하는 방법
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
EP2778233B1 (en) 2011-11-10 2017-01-11 Human Metabolome Technologies, Inc. Method for measuring ethanolamine phosphate
KR20150035818A (ko) 2012-06-15 2015-04-07 해리 스타일리 순환 병든 세포를 사용하여 질환 또는 병태를 검출하는 방법
MX2014015425A (es) 2012-06-15 2015-07-14 Harry Stylli Metodos para detectar enfermedades o condiciones.
WO2014068144A1 (en) 2012-11-05 2014-05-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
EP4202441A3 (en) 2013-03-09 2023-07-26 Immunis.AI, Inc. Gene expression profile in macrophages for the diagnosis of cancer
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
US11806385B2 (en) 2016-04-22 2023-11-07 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
US11079329B2 (en) * 2017-09-27 2021-08-03 University of North Carolina Wilmington Human waste water and human-derived pathogen scouting tool
KR102699211B1 (ko) 2018-03-19 2024-08-26 후지필름 가부시키가이샤 정신 질환의 판정 방법
JP6678982B2 (ja) * 2018-03-22 2020-04-15 株式会社 日本医療機器技研 生体吸収性ステント
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
WO2021106724A1 (ja) * 2019-11-26 2021-06-03 京セラ株式会社 ストレス計測システムおよびストレス計測方法
WO2022075354A1 (en) * 2020-10-06 2022-04-14 Okinawa Institute Of Science And Technology School Corporation A method for obtaining an index for the diagnosis of alzheimer's disease (ad)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
ATE534038T1 (de) 2011-12-15
HK1137219A1 (en) 2010-07-23
WO2006105907A1 (en) 2006-10-12
PL2146209T3 (pl) 2012-05-31
PT1866650E (pt) 2010-06-01
JP4958893B2 (ja) 2012-06-20
DE602006014379D1 (de) 2010-07-01
JP2008537111A (ja) 2008-09-11
SI1866650T1 (sl) 2010-12-31
ES2377704T3 (es) 2012-03-30
US20120196300A1 (en) 2012-08-02
EP2146209B1 (en) 2011-11-16
PT2146209E (pt) 2011-12-30
NO20120452L (no) 2007-11-06
EP2146209A1 (en) 2010-01-20
PL1866650T3 (pl) 2011-04-29
EP1866650B1 (en) 2010-05-19
DK1866650T3 (da) 2010-09-06
EP1866650A1 (en) 2007-12-19
DK2146209T3 (da) 2012-02-13
CY1110116T1 (el) 2015-01-14
ES2346467T3 (es) 2010-10-15
ATE468537T1 (de) 2010-06-15
US20080131921A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
NO20075671L (no) Neurodegenerative markorer for psykiatriske tilstander
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
CY1112737T1 (el) Ισοτοπικα σεσημασμενες ενωσεις βενζοfuran σαν παραγοντες απεικονισης για πρωτεϊνες δημιουργιας αμυλοειδους (αμυloid)
WO2005047484A3 (en) Biomarkers for alzheimer's disease
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
EP1700096A4 (en) PROOF OF PROTEINS AND PRIONS WITH CHANGED CONFORMATION
EP1855525A4 (en) FISH MODELS ZEBRA OF ALZHEIMER'S DISEASE
DE602004006664D1 (de) Vorrichtung zum Feststellen der Verschlechterung eines Sauerstoffkonzentrationsensors
DK1330656T3 (da) Midler til detektion af patologiske transformationer af proteinet APP og anvendelser heraf
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
DK1639139T3 (da) Fremgangsmåder til påvisning af Alzheimers sygdom
NO20030216D0 (no) Fremgangsmåte for å detektere patogene prionproteiner ved hjelp av massespektroskopi
DK1558929T3 (da) Kvantificering af stresseksponering
FR2852096B1 (fr) Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque.
GB0622194D0 (en) Method for diagnosing or detecting alzheimer's disease
ATE442084T1 (de) Messung des energieverbrauchs
EP1907838A4 (en) FRAGMENT OF THE NEUROSCRETOR PROTEIN VGF AS BIOMARKER FOR MORBUS ALZHEIMER
UA11938S (uk) Кашкет чоловічий формений
UA11937S (uk) Кашкет чоловічий формений
FR2918183B1 (fr) Procedes de detection automatique du materiau de lunettes, de forme d'une monture et de detourage des lentilles associees a une monture.
ATE459354T1 (de) Neue azabicycloä3.2.1üoct-2-en-derivate und ihre verwendung als monoamin-neurotransmitter- wiederaufnahmeinhibitoren
GB0517317D0 (en) Alex's cycle indicator
FR2871587B3 (fr) Monture de lunettes avec mecanisme de fixation magnetique non apparent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application